556 results on '"Research Centre for Stroke '
Search Results
2. Berlin PRehospital Or Usual Delivery of Acute Stroke Care 2.0 (B_PROUD 2.0)
- Author
-
Center for Stroke Research Berlin and Heinrich J Audebert, Prof. Dr. med., MD, Neurologist, Head of Dept. of Neurology at Campus Benjamin Franklin, Charité - Universitaetsmedizin Berlin
- Published
- 2024
3. Using Big Data to Conduct Innovative Cardiovascular Clinical Trials
- Author
-
Knowledge Translation Program of St. Michael's Hospital, Heart and Stroke Foundation of Ontario, Heart & Stroke Richard Lewar Centres of Excellence in Cardiovascular Research, CorHealth Ontario, The Ontario Spor Support Unit, and Dr. Jacob Udell, Co-Principal Investigator
- Published
- 2023
4. Managing Aftercare for Stroke (MAS): MAS-II - A Longitudinal Complex-interventional Study in Post-rehabilitation Stroke Patients
- Author
-
Center for Stroke Research Berlin, Hebrew University of Jerusalem, NeuroCure Clinical Research Center, Charite, Berlin, and Andreas Meisel, Prof. Dr. med.
- Published
- 2022
5. Berlin Atrial Fibrillation Registry
- Author
-
Center for Stroke Research Berlin, Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma, and Karl Georg Haeusler, Prof.
- Published
- 2020
6. Berlin PRehospital Or Usual Delivery of Acute Stroke Care (B_PROUD)
- Author
-
Center for Stroke Research Berlin and Heinrich J Audebert, Prof. Dr. med.
- Published
- 2020
7. iTBS Methods and Motor Cortex Excitability
- Author
-
MUSC Center for Biomedical Research Excellence in Stroke Recovery
- Published
- 2020
8. Imaging Laterality in Chronic Stroke Patients
- Author
-
MUSC Center for Biomedical Research Excellence in Stroke Recovery
- Published
- 2019
9. Computerised Assessment of Visual Neglect Symptoms in Peripersonal Space (KMS-Neglect 2)
- Author
-
Median Klinik Berlin-Kladow, NeuroCure Clinical Research Center, Charite, Berlin, Center for Stroke Research Berlin, Free University of Berlin, Humboldt-Universität zu Berlin, and Andreas Meisel, Prof. Dr. med. Andreas Meisel
- Published
- 2018
10. Accuracy of citrulline, I-FABP and d-lactate in the diagnosis of acute mesenteric ischemia
- Author
-
Alexandre Nuzzo, Kevin Guedj, Sonja Curac, Claude Hercend, Claude Bendavid, Nathalie Gault, Alexy Tran-Dinh, Maxime Ronot, Antonino Nicoletti, Yoram Bouhnik, Yves Castier, Olivier Corcos, Katell Peoc’h, and The SURVI (Structure d’URgences Vasculaires Intestinales) Research Group (French Intestinal Stroke Center)
- Subjects
Medicine ,Science - Abstract
Abstract Early diagnosis of acute mesenteric ischemia (AMI) remains a clinical challenge, and no biomarker has been consistently validated. We aimed to assess the accuracy of three promising circulating biomarkers for diagnosing AMI—citrulline, intestinal fatty acid-binding protein (I-FABP), and d-lactate. A cross-sectional diagnostic study enrolled AMI patients admitted to the intestinal stroke center and controls with acute abdominal pain of another origin. We included 129 patients—50 AMI and 79 controls. Plasma citrulline concentrations were significantly lower in AMI patients compared to the controls [15.3 μmol/L (12.0–26.0) vs. 23.3 μmol/L (18.3–29.8), p = 0.001]. However, the area under the receiver operating curves (AUROC) for the diagnosis of AMI by Citrulline was low: 0.68 (95% confidence interval = 0.58–0.78). No statistical difference was found in plasma I-FABP and plasma d-lactate concentrations between the AMI and control groups, with an AUROC of 0.44, and 0.40, respectively. In this large cross-sectional study, citrulline, I-FABP, and d-lactate failed to differentiate patients with AMI from patients with acute abdominal pain of another origin. Further research should focus on the discovery of new biomarkers.
- Published
- 2021
- Full Text
- View/download PDF
11. HEart and BRain Interfaces in Acute Ischemic Stroke (HEBRAS)
- Author
-
Center for Stroke Research Berlin and Karl Georg Haeusler, Prof.
- Published
- 2018
12. Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI (DAPT-TAVI)
- Author
-
Prof. Dr. Jochen Fiebach, Center for Stroke Research Berlin (CSB), Charité - Universitaetsmedizin Berlin and Alexander Lauten, Prof. Dr. med.
- Published
- 2016
13. Berlin Beat of Running Study
- Author
-
Center for Stroke Research Berlin, Medical Institute BMW-Berlin Marathon, Berlin, Germany, and Karl Georg Haeusler, MD
- Published
- 2016
14. Cardiac MRI in Ischemic Stroke Study (CaMriSS)
- Author
-
Center for Stroke Research Berlin, Cardiology and Angiology, Elisabeth Hospital, Essen, Germany, and Karl Georg Haeusler, MD
- Published
- 2016
15. PHANTOM-S: The Pre-Hospital Acute Neurological Therapy and Optimization of Medical Care in Stroke Patients - Study (PHANTOM-S)
- Author
-
Berlin Firebrigade, MEYTEC GmbH, B.R.A.H.M.S GmbH ThermoFisher Scientific, Federal Ministry of Education and Research via Center for Stroke Research Berlin (CSB), European Union, Berlin Technology Foundation (EFRE), The Volkswagen Foundation, German Research Foundation, and Heinrich Audebert/ Prof. Dr. med.
- Published
- 2015
16. Patient Satisfaction in Stroke Patients (PatZuFrie)
- Author
-
Center for Stroke Research Berlin, German Federal Ministry of Education and Research, and Christian H Nolte MD
- Published
- 2010
17. In-hospital recruitment to observational studies of stroke.
- Author
-
Pickering RM, Kunkel D, Fitton C, Ashburn A, Jenkinson D, and Stroke Association Rehabilitation and Research Centre Team
- Published
- 2010
- Full Text
- View/download PDF
18. Going home to get on with life: patients and carers [sic] experiences of being discharged from hospital following a stroke.
- Author
-
Ellis-Hill C, Robison J, Wiles R, McPherson K, Hyndman D, Ashburn A, and Stroke Association Rehabilitation Research Centre Team
- Abstract
Purpose. In this paper we aim to develop the understanding of what constitutes a 'good' or 'poor' experience in relation to the transition from hospital to home following a stroke. Method. Semi-structured interviews were carried out with 20 people and 13 carers within one month of being discharged from hospital following a stroke. Interviews covered views of mobility recovery and support from therapy and services. Interviews were transcribed verbatim, coded and analysed in depth in order to explore the discharge process. Results. Participants described models of recovery, which involved a sense of momentum and getting on with their life. Discharge was successful if: (i) This sense of momentum was maintained, (ii) they felt supported, and (iii) they felt informed about what was happening. Discharge was seen as difficult when: (a) Momentum was perceived to be lost, (b) people did not feel supported, or (c) they felt in the dark about the plans or their recovery. Conclusions. The discharge experience could be improved by healthcare professionals understanding and exploring patients' individual models of recovery. This would allow professionals to: (a) Access patients concerns, (b) develop programmes addressing these, (c) correct misinterpretations, (d) keep people fully informed, and (e) share and validate the experience, to reduce their sense of isolation. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
19. Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Ischemic Stroke (SERIC-AIS)
- Author
-
Yi Yang, Clinical Trial and Research Center for Stroke
- Published
- 2024
20. Developing person-centred goal setting resources with and for people with aphasia: A multi-phase qualitative study
- Author
-
<p>National Health and Medical Research Council Centre for Research Excellence Stroke Rehabilitation and Recovery National Heart Foundation of Australia Centre for Research Excellence</p>, Elston, Amanda, Barnden, Rebecca, Hersh, Deborah, Godecke, Erin, Cadilhac, Dominique A., Lannin, Natasha A., Kneebone, Ian, Andrew, Nadine E., <p>National Health and Medical Research Council Centre for Research Excellence Stroke Rehabilitation and Recovery National Heart Foundation of Australia Centre for Research Excellence</p>, Elston, Amanda, Barnden, Rebecca, Hersh, Deborah, Godecke, Erin, Cadilhac, Dominique A., Lannin, Natasha A., Kneebone, Ian, and Andrew, Nadine E.
- Abstract
Elston, A., Barnden, R., Hersh, D., Godecke, E., Cadilhac, D. A., Lannin, N. A., ... Andrew, N. E. (2021). Developing person-centred goal setting resources with and for people with aphasia: A multi-phase qualitative study. Aphasiology. Advance online publication. https://doi.org/10.1080/02687038.2021.1907294
21. Stroke Adverse Outcome is Associated With Nosocomial Infections: PCTus- Guided Antibacterial Therapy in Severe Ischemic Stroke Patients (STRAWINSKI) (STRAWINSKI)
- Author
-
Brahms AG, NeuroCure Clinical Research Center, Charite, Berlin, and Andreas Meisel, Prof. Dr. Andreas Meisel, Charité University, Berlin, Germany (Center for Stroke Research Berlin CSB & NeuroCure Clinical Research Center NCRC)
- Published
- 2021
22. Improving Medication Self-Administration and Health After Brain Injury
- Author
-
A. M. Barrett, MD, Director, Center for Stroke Rehabilitation Research
- Published
- 2021
23. The Randomized Controlled STRAWINSKI Trial: Procalcitonin-Guided Antibiotic Therapy after Stroke
- Author
-
Andreas Meisel, Lena Ulm, Sarah Hoffmann, Darius Nabavi, Marcella Hermans, Bruno-Marcel Mackert, Frank Hamilton, Ingo Schmehl, Gerhard-Jan Jungehuelsing, Joan Montaner, Alejandro Bustamante, Mira Katan, Andreas Hartmann, Stefan Ebmeyer, Christiane Dinter, Jan C. Wiemer, Sabine Hertel, Christian Meisel, Stefan D. Anker, University of Zurich, Meisel, Andreas, Institut Català de la Salut, [Ulm L] NeuroCure Clinical Research Center, Charité – Universitaetsmedizin Berlin, Berlin, Germany. Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia. Department of Neurology and Center for Stroke Research Berlin, Charité – Universitaetsmedizin Berlin, Berlin, Germany. [Hoffmann S] NeuroCure Clinical Research Center, Charité – Universitaetsmedizin Berlin, Berlin, Germany. Department of Neurology and Center for Stroke Research Berlin, Charité – Universitaetsmedizin Berlin, Berlin, Germany. [Nabavi D, Hermans M] Department of Neurology, Vivantes Klinikum Neukoelln, Berlin, Germany. [Mackert BM, Hamilton F] Department of Neurology, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany. [Montaner J, Bustamante A] Grup Malalties neurovasculars, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Pneumònia ,030204 cardiovascular system & hematology ,Other subheadings::Other subheadings::/drug therapy [Other subheadings] ,600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit ,Procalcitonin ,lcsh:RC346-429 ,biomarker-guided treatment ,Cardiovascular Diseases::Heart Diseases::Myocardial Ischemia::Myocardial Infarction [DISEASES] ,0302 clinical medicine ,Modified Rankin Scale ,Clinical endpoint ,infections ,Antibiotic prophylaxis ,Stroke ,Outcome ,education.field_of_study ,antibiotic prophylaxis ,stroke, pneumonia, antibiotic prophylaxis, procalcitonin, outcome, infections, biomarker-guided treatment ,Clinical Trial ,stroke ,enfermedades cardiovasculares::enfermedades cardíacas::isquemia miocárdica::infarto de miocardio [ENFERMEDADES] ,3. Good health ,2728 Neurology (clinical) ,Neurology ,outcome ,procalcitonin ,medicine.medical_specialty ,enfermedades respiratorias::enfermedades pulmonares::neumonía [ENFERMEDADES] ,Population ,Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores] ,610 Medicine & health ,Infections ,Respiratory Tract Diseases::Lung Diseases::Pneumonia [DISEASES] ,Sepsis ,03 medical and health sciences ,Internal medicine ,medicine ,pneumonia ,Biomarker-guided treatment ,education ,lcsh:Neurology. Diseases of the nervous system ,business.industry ,Pneumonia ,medicine.disease ,Surgery ,10040 Clinic for Neurology ,Infart de miocardi ,2808 Neurology ,Neurology (clinical) ,Medicaments - Administració ,business ,030217 neurology & neurosurgery ,Neuroscience - Abstract
Profilaxi antibiòtica; Infeccions; Pneumònia Profilaxis antibiótica; Infecciones; Neumonía Antibiotic prophylaxis; Infections; Pneumonia Background: Pneumonia is among the most common acute complications after stroke and is associated with poor long-term outcome. Biomarkers may help identifying stroke patients at high risk for developing stroke-associated pneumonia (SAP) and to guide early treatment. Aims: This trial investigated whether procalcitonin (PCT) ultrasensitive (PCTus)-guided antibiotic treatment of SAP can improve functional outcome after stroke. Methods: In this international, multicenter, randomized, controlled clinical trial with blinded assessment of outcomes, patients with severe ischemic stroke in the middle cerebral artery territory were randomly assigned within 40 h after symptom onset to PCTus-based antibiotic therapy guidance in addition to stroke unit care or standard stroke unit care alone. The primary endpoint was functional outcome at 3 months, defined according to the modified Rankin Scale (mRS) and dichotomized as acceptable (≤4) or unacceptable (≥5). Secondary endpoints included usage of antibiotics, infection rates, days of fever, and mortality. The trial was registered with http://ClinicalTrials.gov (Identifier NCT01264549). Results: In the intention-to-treat-analysis based on 227 patients (112 in PCT and 115 in control group), 197 patients completed the 3-month follow-up. Adherence to PCT guidance was 65%. PCT-guided therapy did not improve functional outcome as measured by mRS (odds ratio 0.79; 95% confidence interval 0.45–1.35, p = 0.47). Pneumonia rate and mortality were similar in both groups. Days with fever tended to be lower (p = 0.055), whereas total number of days treated with antibiotics were higher (p = 0.004) in PCT compared to control group. A post hoc analysis including all PCT values in the intention-to-treat population demonstrated a significant increase on the first day of infection in patients with pneumonia and sepsis compared to patients with urinary tract infections or without infections (p < 0.0001). Conclusion: PCTus-guided antibiotic therapy did not improve functional outcome at 3 months after severe ischemic stroke. PCT is a promising biomarker for early detection of pneumonia and sepsis in acute stroke patients. This trial was supported by the European Union (FP7/2008-2013; 201024 and 202213), the German Ministry for Health and Education (01EO0801), the German Research Foundation (Exc257, SFB-TRR84, UL423/1-1), and Thermo Fisher Scientific BRAHMS GmbH, Germany.
- Published
- 2017
24. TU-H-CAMPUS-IeP3-02: Neurovascular 4D Parametric Imaging Using Co-Registration of Biplane DSA Sequences with 3D Vascular Geometry Obtained From Cone Beam CT
- Author
-
Ionita, C [Toshiba Stroke and Vascular Research Centre, SUNY at Buffalo (United States)]
- Published
- 2016
- Full Text
- View/download PDF
25. TU-D-209-05: Automatic Calculation of Organ and Effective Dose for CBCT and Interventional Fluoroscopic Procedures
- Author
-
Bednarek, D [Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY (United States)]
- Published
- 2016
- Full Text
- View/download PDF
26. TU-D-209-02: A Backscatter Point Spread Function for Entrance Skin Dose Determination
- Author
-
Bednarek, D [Toshiba Stroke and Vascular Research Center, University at Buffalo (SUNY), Buffalo, NY (United States)]
- Published
- 2016
- Full Text
- View/download PDF
27. MO-FG-CAMPUS-IeP1-04: Kerma Area Product Calculation for Non-Uniform X-Ray Fields Using a Skin Dose Tracking System
- Author
-
Bednarek, D [Toshiba Stroke and Vascular Research Center, University at Buffalo (SUNY), Buffalo, NY (United States)]
- Published
- 2016
- Full Text
- View/download PDF
28. SU-G-206-05: A Comparison of Head Phantoms Used for Dose Determination in Imaging Procedures
- Author
-
Bednarek, D [Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY (United States)]
- Published
- 2016
- Full Text
- View/download PDF
29. SU-C-209-03: Anti-Scatter Grid-Line Artifact Minimization for Removing the Grid Lines for Three Different Grids Used with a High Resolution CMOS Detector
- Author
-
Rudin, S [Toshiba Stroke and Vascular Research Center, University at Buffalo, NY (United States)]
- Published
- 2016
- Full Text
- View/download PDF
30. Cerebral Microbleeds and Treatment Effect of Intravenous Thrombolysis in Acute Stroke:An Analysis of the WAKE-UP Randomized Clinical Trial
- Author
-
Norbert Nighoghossian, Jan Vynckier, Josep Puig, Vincent Thijs, Claus Z Simonsen, Tim Bastian Braemswig, Götz Thomalla, Märit Jensen, Florent Boutitie, Ivana Galinovic, Christian H. Nolte, Christian Gerloff, Bastian Cheng, Martin Ebinger, Keith W. Muir, Jens Fiehler, Salvador Pedraza, Robin Lemmens, Matthias Endres, Jochen B. Fiebach, Ludwig Schlemm, Wake-Up investigators, Tae-Hee Cho, CarMeN, laboratoire, Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Klinik für Neurologie, Westfälische Wilhelms-Universität Münster = University of Münster (WWU), Humboldt University Of Berlin, Berlin Institute of Health (BIH), Center for Stroke Research Berlin, Freie Universität Berlin, Hospices Civils de Lyon (HCL), Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Bern University Hospital [Berne] (Inselspital), Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Aarhus University Hospital, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Université de Lyon-Université de Lyon-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Josep Trueta University Hospital, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta - Girona Biomedical Research Institute (IDIBGI), University of Glasgow, German Center for Cardiovascular Research (DZHK), German Research Center for Neurodegenerative Diseases - Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), University Hospitals Leuven [Leuven], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), and VIB Center for Brain & Disease Research [Leuven, Belgium]
- Subjects
Male ,medicine.medical_specialty ,[SDV]Life Sciences [q-bio] ,medicine.medical_treatment ,Placebo ,law.invention ,Fibrinolytic Agents ,Randomized controlled trial ,law ,Modified Rankin Scale ,Internal medicine ,diagnostic imaging [Stroke] ,medicine ,Humans ,ddc:610 ,Prospective Studies ,Stroke ,adverse effects [Tissue Plasminogen Activator] ,Ischemic Stroke ,Intracerebral hemorrhage ,drug therapy [Cerebral Hemorrhage] ,business.industry ,methods [Thrombolytic Therapy] ,Thrombolysis ,Odds ratio ,diagnostic imaging [Cerebral Hemorrhage] ,adverse effects [Thrombolytic Therapy] ,medicine.disease ,etiology [Cerebral Hemorrhage] ,drug therapy [Stroke] ,[SDV] Life Sciences [q-bio] ,Treatment Outcome ,Clinical research ,Tissue Plasminogen Activator ,Neurology (clinical) ,business - Abstract
Background and ObjectivesCerebral microbleeds (CMBs) are common in patients with acute ischemic stroke and are associated with increased risk of intracerebral hemorrhage (ICH) after intravenous thrombolysis. Whether CMBs modify the treatment effect of thrombolysis is unknown.MethodsWe performed a prespecified analysis of the prospective randomized controlled multicenter Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke (WAKE-UP) trial including patients with acute ischemic stroke with unknown time of symptom onset and diffusion-weighted imaging–fluid-attenuated inversion recovery mismatch on MRI receiving alteplase or placebo. Patients were screened and enrolled between September 2012 and June 2017 (with final follow-up in September 2017). Patients were randomized to treatment with IV thrombolysis with alteplase at 0.9 mg/kg body weight or placebo. CMB status (presence, number, and distribution) was assessed after study completion by 3 raters blinded to clinical information following a standardized protocol. Outcome measures were excellent functional outcome at 90 days, defined by modified Rankin Scale (mRS) score ≤1, and symptomatic ICH according to National Institutes of Neurological Disease and Stroke trial criteria 22 to 36 hours after treatment.ResultsOf 503 patients enrolled in the WAKE-UP trial, 459 (91.3%; 288 [63%] men) were available for analysis. Ninety-eight (21.4%) had at least 1 CMB on baseline imaging; 45 (9.8%) had exactly 1 CMB; 37 (8.1%) had 2 to 4 CMBs; and 16 (3.5%) had ≥5 CMBs. Presence of CMBs was associated with a nonsignificant increased risk of symptomatic ICH (11.2% vs 4.2%; adjusted odds ratio [OR] 2.32, 95% confidence interval [CI] 0.99–5.43, p = 0.052) but had no effect on functional outcome at 90 days (mRS score ≤1: 45.8% vs 50.7%; adjusted OR 0.99, 95% CI 0.59–1.64, p = 0.955). Patients receiving alteplase had better functional outcome (mRS score ≤1: 54.6% vs 44.6%, adjusted OR 1.61, 95% CI 1.07–2.43, p = 0.022) without evidence of heterogeneity in relation to CMB presence (p of the interactive term = 0.546). Results were similar for subpopulations with strictly lobar (presumed cerebral amyloid angiopathy related) or not strictly lobar CMB distribution.DiscussionIn the randomized-controlled WAKE-UP trial, we saw no evidence of reduced treatment effect of alteplase in patients with acute ischemic stroke with ≥1 CMBs. Additional studies are needed to determine the treatment effect of alteplase and its benefit-harm ratio in patients with a larger number of CMBs.Trial Registration InformationClinicalTrials.gov identifier NCT01525290; ClinicalTrialsRegister.EU identifier 2011-005906-32.Classification of EvidenceThis study provides Class II evidence that for patients with acute ischemic stroke with unknown time of onset and diffusion-weighted imaging–fluid-attenuated inversion recovery mismatch who received IV alteplase, CMBs are not significantly associated with functional outcome at 90 days.
- Published
- 2022
31. WE-G-204-06: Grid-Line Artifact Minimization for High Resolution Detectors Using Iterative Residual Scatter Correction
- Author
-
Rudin, S [Toshiba Stroke & Vascular Research Center, University at Buffalo, Buffalo, NY (United States)]
- Published
- 2015
- Full Text
- View/download PDF
32. WE-G-204-04: Focal Spot Deblurring For High Resolution Amorphous Selenium (aSe) Complementary Metal Oxide Semiconductor (CMOS) X-Ray Detector
- Author
-
Rudin, S [Toshiba Stroke and Vascular Research Center, University at Buffalo, SUNY (United States)]
- Published
- 2015
- Full Text
- View/download PDF
33. TU-F-CAMPUS-I-05: Investigation of An EMCCD Detector with Variable Gain in a Micro-CT System
- Author
-
Bednarek, D [Toshiba Stroke and Vascular Research Center at SUNY Buffalo, Buffalo, NY (United States)]
- Published
- 2015
- Full Text
- View/download PDF
34. MO-F-CAMPUS-I-01: A System for Automatically Calculating Organ and Effective Dose for Fluoroscopically-Guided Procedures
- Author
-
Bednarek, D [Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY (United States)]
- Published
- 2015
- Full Text
- View/download PDF
35. SU-E-I-55: The Contribution to Skin Dose Due to Scatter From the Patient Table and the Head Holder During Fluoroscopy
- Author
-
Bednarek, D [Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY (United States)]
- Published
- 2015
- Full Text
- View/download PDF
36. SU-E-I-53: Comparison of Kerma-Area-Product Between the Micro-Angiographic Fluoroscope (MAF) and a Flat Panel Detector (FPD) as Used in Neuro-Endovascular Procedures
- Author
-
Bednarek, D [Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY (United States)]
- Published
- 2015
- Full Text
- View/download PDF
37. SU-D-204-05: Quantitative Comparison of a High Resolution Micro-Angiographic Fluoroscopic (MAF) Detector with a Standard Flat Panel Detector (FPD) Using the New Metric of Generalized Measured Relative Object Detectability (GM-ROD)
- Author
-
Rudin, S [Toshiba Stroke and Vascular Research Center, University at Buffalo (SUNY), Buffalo, NY (United States)]
- Published
- 2015
- Full Text
- View/download PDF
38. Accuracy of citrulline, I-FABP and d-lactate in the diagnosis of acute mesenteric ischemia
- Author
-
Katell Peoc'h, Alexy Tran-Dinh, Nathalie Gault, Yoram Bouhnik, Kevin Guedj, Antonino Nicoletti, Yves Castier, Claude Hercend, Alexandre Nuzzo, Olivier Corcos, Maxime Ronot, Claude Bendavid, Sonja Curac, Hôpital Beaujon [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Université Sorbonne Paris Nord, Nutrition, Métabolismes et Cancer (NuMeCan), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), CHU Pontchaillou [Rennes], AP-HP - Hôpital Bichat - Claude Bernard [Paris], Centre d'investigation Clinique [CHU Bichat] - Épidémiologie clinique (CIC 1425), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de recherche sur l'Inflammation (CRI (UMR_S_1149 / ERL_8252 / U1149)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), SURVI (Structure d’URgences Vasculaires Intestinales) Research Group (French Intestinal Stroke Center): Audrey Huguet, Carmen Stefanescu, Xavier Treton, Francisca Joly, Lore Billiauws, Annick Hamon, Aureline Boitet, Céline Lekhal, David Deutsch, Elsa Oiknin, Laura Cohen, Gabriel Marcellier, Jean Senemaud, Felix Corre, Damien Soudan, Cosmin Voican, Jean-Baptiste Leclère, Jules Iquilles, Lucas Raynaud, Luisa Paulatto, Manon Haas, Mathieu Uzzan, Mathilde Cohen, Sara Tadbiri, Servane Prevot, Yves Panis, Alice Frontali, Simon Msika, Lara Ribeiro, Lionel Rebibo, Konstantinos Arapis, Marion Orville, Annie Sibert, Pauline Copin, Magaly Zappa, Marco Dioguardi Burgio, Valérie Vilgrain, Caroline Bertin, Anne Kerbaol, Wassim Allaham, Quentin Pellenc, Arnaud Roussel, Pierre Cerceau, Iannis Ben Abdallah, Antoine Girault, Pierre Mordant, Romain De Blic, Catherine Paugam, Emmanuel Weiss, Paer-Selim Abback, Isabelle Enriquez, Sylvie Janny, Helene Bout, Mikhael Giabicani, Marina Achouf, Bénédicte Grigoresco, Linda Koy Ear, Sonja Curac, Agnès Cachier, Aurelie Plessier, Pierre-Emmanuel Rautou, Dominique Valla, Audrey Payancé, Alain Sauvanet, Safi Dokmak, Federica Dondero, Ailton Sepulveda, Olivier Farges, Beatrice Aussilhou, Bénédicte Jais, Dominique Cazals-Hatem, Emmanuelle De Raucourt, Larbi Boudaoud, Catherine Trichet, Herve Puy, Nathalie Pons-Kerjean, Jeanick Stocco, Julie Bataille, Valérie Bouton, Philippe Montravers, Pascal Augustin, Brice Lortat Jacob, Jean-Baptiste Michel, Dominique Gauguier, Marc-Emmanuel Dumas, François Brial, Antonis Myridakis, Laura Martinez-Gili, Michael Olanipekun, Estelle Marcault, Cindie Nilusmas, Anne Barnier, Aminata Souare, Grants from MSD-Avenir and APHP funded the SURVIBIO study, Alexandre Nuzzo received Ph.D. Grants from 'Fondation de l'Avenir' and the French Gastroenterology Society (SNFGE)., Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), and Jonchère, Laurent
- Subjects
Male ,[SDV]Life Sciences [q-bio] ,Statistical difference ,Acute abdominal pain ,Diseases ,Gastroenterology ,chemistry.chemical_compound ,0302 clinical medicine ,Acute mesenteric ischemia ,Citrulline ,Stroke ,Abdomen, Acute ,Multidisciplinary ,PLASMA CITRULLINE ,CELIAC-DISEASE ,Middle Aged ,ACID-BINDING-PROTEIN ,3. Good health ,Multidisciplinary Sciences ,[SDV] Life Sciences [q-bio] ,030220 oncology & carcinogenesis ,Science & Technology - Other Topics ,Medicine ,Biomarker (medicine) ,Female ,030211 gastroenterology & hepatology ,Adult ,medicine.medical_specialty ,VILLOUS ATROPHY ,Science ,Cardiology ,Fatty Acid-Binding Proteins ,Article ,INTESTINAL ISCHEMIA ,03 medical and health sciences ,[CHIM.ANAL]Chemical Sciences/Analytical chemistry ,Internal medicine ,MANAGEMENT ,medicine ,Humans ,Lactic Acid ,cardiovascular diseases ,Aged ,Science & Technology ,business.industry ,[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology ,medicine.disease ,SERUM D(-)-LACTATE LEVELS ,SURVI (Structure d’URgences Vasculaires Intestinales) Research Group (French Intestinal Stroke Center) ,Circulating biomarkers ,SEROLOGICAL MARKERS ,Cross-Sectional Studies ,Early Diagnosis ,chemistry ,Mesenteric Ischemia ,ENTEROCYTE MASS ,Tomography, X-Ray Computed ,D lactate ,business ,Biomarkers - Abstract
Early diagnosis of acute mesenteric ischemia (AMI) remains a clinical challenge, and no biomarker has been consistently validated. We aimed to assess the accuracy of three promising circulating biomarkers for diagnosing AMI—citrulline, intestinal fatty acid-binding protein (I-FABP), and d-lactate. A cross-sectional diagnostic study enrolled AMI patients admitted to the intestinal stroke center and controls with acute abdominal pain of another origin. We included 129 patients—50 AMI and 79 controls. Plasma citrulline concentrations were significantly lower in AMI patients compared to the controls [15.3 μmol/L (12.0–26.0) vs. 23.3 μmol/L (18.3–29.8), p = 0.001]. However, the area under the receiver operating curves (AUROC) for the diagnosis of AMI by Citrulline was low: 0.68 (95% confidence interval = 0.58–0.78). No statistical difference was found in plasma I-FABP and plasma d-lactate concentrations between the AMI and control groups, with an AUROC of 0.44, and 0.40, respectively. In this large cross-sectional study, citrulline, I-FABP, and d-lactate failed to differentiate patients with AMI from patients with acute abdominal pain of another origin. Further research should focus on the discovery of new biomarkers.
- Published
- 2021
39. SU-E-CAMPUS-I-04: Automatic Skin-Dose Mapping for An Angiographic System with a Region-Of-Interest, High-Resolution Detector
- Author
-
Bednarek, D [Department of Radiology, Department of Physiology and Biophysics, Toshiba Stroke and Vascular Research Center (United States)]
- Published
- 2014
- Full Text
- View/download PDF
40. SU-E-I-29: Generalized Relative Object Detectability (G-ROD): A Metric for Comparing X-Ray Imaging Detector Systems
- Author
-
Rudin, S [Toshiba Stroke and Vascular Research Center, University at Buffalo, Buffalo, NY (United States)]
- Published
- 2014
- Full Text
- View/download PDF
41. SU-E-I-22: Dependence On Calibration Phantom and Field Area of the Conversion Factor Used to Calculate Skin Dose During Neuro-Interventional Fluoroscopic Procedures
- Author
-
Bednarek, D [Department of Radiology, Physiology and Biophysics, Toshiba Stroke and Vascular Research Center, University at Buffalo (State University of New York), Buffalo, NY (United States)]
- Published
- 2014
- Full Text
- View/download PDF
42. Evaluation of the microangiographic fluoroscope (MAF) using generalized system performance metrics
- Author
-
Rudin, Stephen [Toshiba Stroke and Vascular Research Center, Department of Radiology, Department of Neurosurgery, Department of Physiology and Biophysics, Department of Mechanical and Aerospace Engineering, Department of Electrical Engineering, and Department of Biomedical Engineering, University at Buffalo, State University of New York, Buffalo, New York 14214 (United States)]
- Published
- 2013
- Full Text
- View/download PDF
43. Accurate MTF measurement in digital radiography using noise response
- Author
-
Rudin, Stephen [Toshiba Stroke Research Center, University at Buffalo, State University of New York, Biomedical Research Building, Room 445, 3435 Main Street, Buffalo, New York 14214 (United States)]
- Published
- 2010
- Full Text
- View/download PDF
44. GGPS1 Mutations Cause Muscular Dystrophy/Hearing Loss/Ovarian Insufficiency Syndrome
- Author
-
Udo Oppermann, Richard S. Finkel, Sandra Donkervoort, Edoardo Malfatti, Mariarita Santi, Leila Qebibo, Thomas Voit, Carsten G. Bönnemann, Kamel Mamchaoui, Michio Hirano, Kate Bushby, Philippe Touraine, Isabelle Nelson, Volker Straub, Hui Xiong, Tanya Stojkovic, Jahannaz Dastgir, A. Reghan Foley, Stephanie Duguez, Thomas C. Markello, Jyoti K. Jaiswal, Jachinta Rooney, Thierry Maisonobe, Ying Hu, Imelda Hughes, Jocelyn Laporte, Norma B. Romero, Katherine G. Meilleur, Johann Böhm, Adam Horn, Yaqun Zou, James E. Dunford, Yanbin Fan, Goutam Chandra, Centre de recherche en Myologie – U974 SU-INSERM, Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologies appliquées (END-ICAP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Neurophysiologie [CHU Pitié-Salpêtrière], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Service de Chirurgie Générale, Viscérale et Endocrinienne [CHU Pitié-Sapêtrière], Unit of Neuromuscular Morphology [CHU Pitié-Salpêtrière], Institut de Myologie, Centre National de la Recherche Scientifique (CNRS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Association française contre les myopathies (AFM-Téléthon)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Association française contre les myopathies (AFM-Téléthon)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), ANR-10-INBS-09 Fondation Maladies Rares, FMR National Institute of Neurological Disorders and Stroke, NINDS, This study was supported by intramural funds from the NIH National Institute of Neurological Disorders and Stroke (grant to C.G.B). J.E.D. is supported by National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom. J.L. and J.B. are supported by France G?nomique (ANR-10-INBS-09) and Fondation Maladies Rares within the framework of the ?Myocapture? sequencing project. We thank the patients and their families for their generous participation in this study, Dr P. Mohassel for his help in evaluating the patients, and M. Pizzimenti for technical assistance., ANR-10-INBS-0009,France-Génomique,Organisation et montée en puissance d'une Infrastructure Nationale de Génomique(2010), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Myologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Institut de Myologie, and Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Association française contre les myopathies (AFM-Téléthon)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Male ,0301 basic medicine ,Pathology ,Geranylgeranyl pyrophosphate ,[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology ,Primary Ovarian Insufficiency ,Muscular Dystrophies ,Protein Structure, Secondary ,Mice ,chemistry.chemical_compound ,0302 clinical medicine ,Medicine ,Gene Knock-In Techniques ,Muscular dystrophy ,Research Articles ,Exome sequencing ,Sanger sequencing ,Geranyltranstransferase ,Middle Aged ,Phenotype ,Pedigree ,3. Good health ,Neurology ,symbols ,Female ,Sensorineural hearing loss ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,GGPS1 ,medicine.symptom ,Research Article ,Adult ,medicine.medical_specialty ,Adolescent ,Hearing loss ,Mice, Transgenic ,Young Adult ,03 medical and health sciences ,symbols.namesake ,Exome Sequencing ,Animals ,Farnesyltranstransferase ,Humans ,Hearing Loss ,business.industry ,Sequence Analysis, DNA ,Dimethylallyltranstransferase ,medicine.disease ,030104 developmental biology ,chemistry ,[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,Mutation ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
International audience; Objective: A hitherto undescribed phenotype of early onset muscular dystrophy associated with sensorineural hearing loss and primary ovarian insufficiency was initially identified in 2 siblings and in subsequent patients with a similar constellation of findings. The goal of this study was to understand the genetic and molecular etiology of this condition. Methods: We applied whole exome sequencing (WES) superimposed on shared haplotype regions to identify the initial biallelic variants in GGPS1 followed by GGPS1 Sanger sequencing or WES in 5 additional families with the same phenotype. Molecular modeling, biochemical analysis, laser membrane injury assay, and the generation of a Y259C knock-in mouse were done. Results: A total of 11 patients in 6 families carrying 5 different biallelic pathogenic variants in specific domains of GGPS1 were identified. GGPS1 encodes geranylgeranyl diphosphate synthase in the mevalonate/isoprenoid pathway, which catalyzes the synthesis of geranylgeranyl pyrophosphate, the lipid precursor of geranylgeranylated proteins including small guanosine triphosphatases. In addition to proximal weakness, all but one patient presented with congenital sensorineural hearing loss, and all postpubertal females had primary ovarian insufficiency. Muscle histology was dystrophic, with ultrastructural evidence of autophagic material and large mitochondria in the most severe cases. There was delayed membrane healing after laser injury in patient-derived myogenic cells, and a knock-in mouse of one of the mutations (Y259C) resulted in prenatal lethality. Interpretation: The identification of specific GGPS1 mutations defines the cause of a unique form of muscular dystrophy with hearing loss and ovarian insufficiency and points to a novel pathway for this clinical constellation. ANN NEUROL 2020;88:332–347.
- Published
- 2020
45. Oxidized low-density lipoprotein induces apoptotic insults to mouse cerebral endothelial cells via a Bax-mitochondria-caspase protease pathway
- Author
-
Chen, R [Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan (China) and Core Laboratories, Wan-Fang Medical Center, Taipei Medical University, Taipei, Taiwan (China) and Topnotch Stroke Research Center, Taipei Medical University, Taipei, Taiwan (China)]
- Published
- 2007
- Full Text
- View/download PDF
46. A U-Net Deep Learning Framework for High Performance Vessel Segmentation in Patients With Cerebrovascular Disease
- Author
-
Michelle, Livne, Jana, Rieger, Orhun Utku, Aydin, Abdel Aziz, Taha, Ela Marie, Akay, Tabea, Kossen, Jan, Sobesky, John D, Kelleher, Kristian, Hildebrand, Dietmar, Frey, Vince I, Madai, and German Federal Ministry of Education and Research through (1) the grant Centre for Stroke Research Berlin and (2) a Go-Bio grant for the research group PREDICTioN2020 (lead: DF)
- Subjects
deep learning framework ,segmentation ,medical imaging ,deep learning ,vessel segmentation ,patients ,Biology ,U-net ,600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit ,Neuroscience ,Original Research ,cerebrovascular disease - Abstract
Brain vessel status is a promising biomarker for better prevention and treatment in cerebrovascular disease. However, classic rule-based vessel segmentation algorithms need to be hand-crafted and are insufficiently validated. A specialized deep learning method-the U-net -is a promising alternative. Using labeled data from 66 patients with cerebrovascular disease, the U-net framework was optimized and evaluated with three metrics: Dice coefficient, 95% Hausdorff distance (95HD) and average Hausdorff distance (AVD). The model performance was compared with the traditional segmentation method of graph-cuts. Training and reconstruction was performed using 2D patches. A full and a reduced architecture with less parameters were trained. We performed both quantitative and qualitative analyses. The U-net models yielded high performance for both the full and the reduced architecture: A Dice value of similar to 0.88, a 95HD of similar to 47 voxels and an AVD of similar to 0.4 voxels. The visual analysis revealed excellent performance in large vessels and sufficient performance in small vessels. Pathologies like cortical laminar necrosis and a rete mirabile led to limited segmentation performance in few patients. The U-net outperfomed the traditional graph-cuts method (Dice similar to 0.76, 95HD similar to 59, AVD similar to 1.97). Our work highly encourages the development of clinically applicable segmentation tools based on deep learning. Future works should focus on improved segmentation of small vessels and methodologies to deal with specific pathologies.
- Published
- 2019
- Full Text
- View/download PDF
47. Novel genetic loci underlying human intracranial volume identified through genome-wide association
- Author
-
G. Bruce Pike, Marcel P. Zwiers, Andreas Meyer-Lindenberg, Jeroen van der Grond, Randy L. Gollub, Karen A. Mather, Andrew J. Schork, Vidar M. Steen, Marc M. Bohlken, Nhat Trung Doan, Derek W. Morris, John B.J. Kwok, Emma J. Rose, Johanna Hass, Andrew Simmons, Tian Ge, Reinhold Schmidt, Micael Andersson, Ian J. Deary, Christopher Chen, Derrek P. Hibar, Simon E. Fisher, Lucija Abramovic, Marcella Rietschel, Edith Hofer, Simon Lovestone, Clyde Francks, Christopher R.K. Ching, Srdjan Djurovic, Lachlan T. Strike, Lorna M. Lopez, Rene L. Olvera, Owen Carmichael, M. Arfan Ikram, Andre F. Marquand, Christine Macare, W.T. Longstreth, Philippe Amouyel, Aaron L. Goldman, Wolfgang Hoffmann, Philip L. De Jager, David C. Liewald, Harald H H Göring, Aad van der Lugt, David Ames, Neeltje E.M. van Haren, Lars Nyberg, Nina Romanczuk-Seiferth, Lukas Pirpamer, Stefan Ehrlich, Alexa S. Beiser, Lianne Schmaal, Hilkka Soininen, Mark Jenkinson, Kazima B. Bulayeva, Anderson M. Winkler, Mike A. Nalls, Diana Tordesillas-Gutiérrez, Martine Hoogman, Lars T. Westlye, Loes M. Olde Loohuis, Andrew Singleton, Gabriel Cuellar-Partida, Randy L. Buckner, Dorret I. Boomsma, Dena G. Hernandez, Steven G. Potkin, Sudha Seshadri, Bertram Müller-Myhsok, D. Hoehn, Gareth E. Davies, Chantal Depondt, Henrik Walter, Michael E. Weale, Deborah Janowitz, Susanne Erk, Iryna O. Fedko, Daniel R. Weinberger, Nic J A van der Wee, Jean-Luc Martinot, Jessica A. Turner, Marieke Klein, Sandra Barral, Sebastian Mohnke, Albert Hofman, Ingrid Melle, Saud Alhusaini, Vincent Chouraki, Stephen M. Lawrie, Mark E. Bastin, Juan C. Troncoso, Jean Shin, Wiro J. Niessen, Diane M. Becker, Laura Almasy, Anders M. Dale, Benjamin S. Aribisala, Dennis van 't Ent, Marco P. Boks, M. Mallar Chakravarty, Paul M. Thompson, David Reese McKay, Michael Griswold, John Blangero, Narelle K. Hansell, Eco J. C. de Geus, Paul A. Nyquist, Susana Muñoz Maniega, Sampath Arepalli, Tatjana Rundek, Dan L. Longo, Anton J. M. de Craen, Rebekah McWhirter, Nazanin Mirza-Schreiber, Henning Tiemeier, Girma Woldehawariat, Sven Cichon, Irene Pappa, Amelia A. Assareh, Sudheer Giddaluru, Pieter J. Hoekstra, Hieab H.H. Adams, Hilleke E. Hulshoff Pol, Grant W. Montgomery, Roel A. Ophoff, Markus M. Nöthen, Sara Pudas, Sigurdur Sigurdsson, Arthur W. Toga, Tien Yin Wong, Massimo Pandolfo, Corina U. Greven, Esther Walton, Tianye Jia, David J. Stott, Gunter Schumann, Marie-José van Tol, Dalia Kasperaviciute, Thomas Wolfers, Henry Völzke, Ian Ford, Shannon L. Risacher, Jessika E. Sussmann, Nicholas G. Martin, Wei Wen, Daniah Trabzuni, Iwona Kłoszewska, Kwangsik Nho, Gianpiero L. Cavalleri, Adam M. Brickman, Sungeun Kim, Andreas Heinz, Ralph L. Sacco, Neda Jahanshad, Velandai Srikanth, Elena Shumskaya, Susan H. Blanton, Katharina Wittfeld, Badri N. Vardarajan, Joshua C. Bis, Joanne E. Curran, Helena Schmidt, Peter T. Fox, Clifford R. Jack, Jason L. Stein, Laura M. E. Blanken, Thomas Espeseth, Dick J. Veltman, Sebastian Guelfi, Margaret J. Wright, Norman Delanty, Michael Czisch, Martina Papmeyer, Oscar L. Lopez, Marjolein M. J. Van Donkelaar, Bruce M. Psaty, Jan K. Buitelaar, Sven J. van der Lee, David A. Bennett, Beng-Choon Ho, Oliver Martinez, Wiepke Cahn, Li Shen, J. Wouter Jukema, Janita Bralten, Peter Kochunov, Greig I. Zubicaray, Marcel P. van der Brug, Ching-Yu Cheng, Philipp G. Sämann, Stella Trompet, Roberto Roiz-Santiañez, David C. Glahn, Allissa Dillman, Venkata S. Mattay, Dara M. Cannon, Michael W. Weiner, Christopher D. Whelan, Alexander Teumer, Sylvane Desrivières, Ole A. Andreassen, Thomas E. Nichols, Manuel Mattheisen, Matthias Nauck, René S. Kahn, Albert V. Smith, Colin Smith, Vilmundur Gudnason, Denis A. Evans, Anouk den Braber, Katie L. McMahon, Han G. Brunner, Florian Holsboer, Yuri Milaneschi, Andrew J. Saykin, Jiemin Liao, Vince D. Calhoun, Neelum T. Aggarwal, Dennis van der Meer, Hans J. Grabe, Anita L. DeStefano, Claudia L. Satizabal, Alan B. Zonderman, Alex P. Zijdenbos, Tulio Guadalupe, Ingrid Agartz, Jordan W. Smoller, Allison C. Nugent, Alejandro Arias-Vasquez, Masashi Ikeda, Avram J. Holmes, Brenda W.J.H. Penninx, John Hardy, Herve Lemaitre, Charles DeCarli, Patrizia Mecocci, Catharina A. Hartman, Tomas Axelsson, Oliver Grimm, Irina Filippi, Wayne C. Drevets, Hans van Bokhoven, Miguel E. Rentería, Aiden Corvin, Ryota Kanai, Kristel R. van Eijk, Andrew M. McIntosh, Jouke-Jan Hottenga, Roberto Toro, Lavinia Athanasiu, Joanna M. Wardlaw, Thomas H. Mosley, Mina Ryten, Meike W. Vernooij, Michelle Luciano, Joshua L. Roffman, Rebecca F. Gottesman, Dhananjay Vaidya, Ryota Hashimoto, Mar Matarin, Adaikalavan Ramasamy, Jerome I. Rotter, Ryan L. Muetzel, Konstantinos Arfanakis, Theo G.M. van Erp, Ganesh Chauhan, Xinmin Liu, Tomáš Paus, Emma Sprooten, Christiane Wolf, David S. Knopman, Manon Bernard, Zdenka Pausova, Bryan J. Traynor, Maria C. Valdés Hernández, Robert C. Green, Russell Thomson, Ravi Duggirala, Lisa R. Yanek, Luigi Ferrucci, Bing Xu, Thomas D. Dyer, Thomas H. Wassink, Eric Westman, Jennifer S. Richards, Phil H. Lee, Benno Pütz, Mark R. Cookson, Benedicto Crespo-Facorro, Natalie A. Royle, Bernd Kraemer, Katrin Hegenscheid, Francis J. McMahon, Tatiana Foroud, M. Kamran Ikram, Myriam Fornage, Nanda Rommelse, Saima Hilal, Perminder S. Sachdev, Qiang Chen, Najaf Amin, Lenore J. Launer, Norbert Hosten, Guillén Fernández, Simone Reppermund, Ashley Beecham, Dirk J. Heslenfeld, Masaki Fukunaga, Cornelia M. van Duijn, Clinton B. Wright, Erik G. Jönsson, Sanjay M. Sisodiya, Oliver Gruber, Christophe Tzourio, André G. Uitterlinden, Robert Johnson, Jaap Oosterlaan, Bernard Mazoyer, H. Ronald Zielke, Stephanie Le Hellard, Jingyun Yang, Georg Homuth, Stéphanie Debette, Nicola J. Armstrong, Sarah E. Medland, Henry Brodaty, Beverly G Windham, Gary Donohoe, Rachel M. Brouwer, James T. Becker, Kumar B. Rajan, Daan van Rooij, Thomas W. Mühleisen, Kazutaka Ohi, Peter R. Schofield, Tonya White, Barbara Franke, Unn K. Haukvik, Debra A. Fleischman, J. Raphael Gibbs, Colm McDonald, Anbupalam Thalamuthu, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Keck School of Medicine [Los Angeles], University of Southern California (USC), Boston University School of Medicine (BUSM), Boston University [Boston] (BU), Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement - U 1167 (RID-AGE), Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Johns Hopkins University (JHU), QIMR Berghofer Medical Research Institute, Leiden University Medical Center (LUMC), Radboud University Medical Center [Nijmegen], Institute of Psychiatry, Psychology & Neuroscience, King's College London, King‘s College London, University of Miami Leonard M. Miller School of Medicine (UMMSM), German Research Center for Neurodegenerative Diseases - Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Greifswald University Hospital, Department of Neurology and Neurosurgery [Montreal], Montreal Neurological Institute and Hospital, McGill University = Université McGill [Montréal, Canada]-McGill University = Université McGill [Montréal, Canada], Royal College of Surgeons in Ireland (RCSI), Umeå University, Illinois Institute of Technology (IIT), Rush University Medical Center [Chicago], University of Edinburgh, Lagos State University (LASU), University of New South Wales [Sydney] (UNSW), Murdoch University, University of Oslo (UiO), Uppsala University, Framingham Heart Study, Boston University [Boston] (BU)-National Heart, Lung, and Blood Institute [Bethesda] (NHLBI), University of Toronto, University of Washington [Seattle], Donders Institute for Brain, Cognition and Behaviour, Radboud university [Nijmegen], Columbia University Medical Center (CUMC), Columbia University [New York], Pennington Biomedical Research Center, Louisiana State University (LSU), McGill University = Université McGill [Montréal, Canada], Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Lieber Institute for Brain Development [Baltimore] (LIBD), University of California [Los Angeles] (UCLA), University of California, Vrije Universiteit Amsterdam [Amsterdam] (VU), Technische Universität Dresden = Dresden University of Technology (TU Dresden), Massachusetts General Hospital [Boston], Neuroimagerie en psychiatrie (U1000), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Sud - Paris 11 (UP11), Maison de Solenn [CHU Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Broad Institute of MIT and Harvard (BROAD INSTITUTE), Harvard Medical School [Boston] (HMS)-Massachusetts Institute of Technology (MIT)-Massachusetts General Hospital [Boston], University of Bergen (UiB), Haukeland University Hospital, Johns Hopkins University School of Medicine [Baltimore], Universität Heidelberg [Heidelberg], University of Mississippi Medical Center (UMMC), International Max Planck Research School for Language Sciences (IMPRS ), Max Planck Institute for Psycholinguistics, Max-Planck-Gesellschaft-Max-Planck-Gesellschaft, Language and Genetics Department [Nijmegen], National University of Singapore (NUS), Medical University Graz, Max Planck Institute of Psychiatry, Max-Planck-Gesellschaft, Yale University [New Haven], University College of London [London] (UCL), Imperial College London, Structure et Réactivité des Systèmes Moléculaires Complexes (SRSMC), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC), Center for Translational Research in Systems Neuroscience and Psychiatry, Department of Psychiatry and Psychotherapy, University Medical Center, Goettingen 37075, Germany, Medstar Research Institute, Clinical And Experimental Epilepsy, Centre for Healthy Brain Ageing, School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, Australia, Department of Biomedicine and the Centre for Integrative Sequencing, Aarhus University [Aarhus], Institute of Human Genetics, University of Bonn, Department of Genomics, Life and Brain Center, Groupe d'imagerie neurofonctionnelle (GIN), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut des Maladies Neurodégénératives [Bordeaux] (IMN), Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS)-Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS), Dpt of Psychiatry [New Haven], Yale University School of Medicine, Department of Psychiatry, VU University Medical Center [Amsterdam], Department of Psychology [Minneapolis], University of Minnesota [Twin Cities] (UMN), University of Minnesota System-University of Minnesota System, Indiana Alzheimer Disease Center, Indiana University School of Medicine, Indiana University System-Indiana University System, Indiana University System, Institute of Food & Health, University College Dublin, University College Dublin [Dublin] (UCD), Statistical Genetics Group, Respiratory Epidemiology and Public Health, Imperial College London-School of public health, The University of Hong Kong (HKU)-The University of Hong Kong (HKU)-MRC-HPA Centre for Environment and Health, Centro de Investigación Biomédica en Red Salud Mental [Madrid] (CIBER-SAM), Karakter Child and Adolescent Psychiatry University Centre [Nijmegen], Institut Parisien de Chimie Moléculaire (IPCM), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS), INSERM, Neuroepidemiology U708, Bordeaux, France, Department of Cognitive Sciences [San Diego], University of California [San Diego] (UC San Diego), University of California-University of California, Department of Neurosciences [San Diego], Centre for Advanced Imaging, University of Queensland, Brisbane 4072, Australia, School of Psychology, University of Queensland, Brisbane 4072, Australia, University of Queensland [Brisbane], Queensland Institute of Medical Research, Génétique humaine et fonctions cognitives - Human Genetics and Cognitive Functions (GHFC (UMR_3571 / U-Pasteur_1)), Institut Pasteur [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Department of Genetics, King Faisal Specialist Hospital and Research Centre, Reta Lila Weston Institute and Department of Molecular Neuroscience, UCL, Institute of Neurology [London], Depts of Radiology, University of Twente [Netherlands], Department of Psychiatry and Human Behavior [Irvine], University of California [Irvine] (UCI), Donders Center for Cognitive Neuroimaging, Donders Centre for Cognitive Neuroimaging, Radboud university [Nijmegen]-Radboud university [Nijmegen], Centre épigénétique et destin cellulaire (EDC (UMR_7216)), Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7), Department of Psychology [Oslo], Faculty of Social Sciences [Oslo], University of Oslo (UiO)-University of Oslo (UiO), Deutsche Bundesbank, National Institutes of Health [Bethesda] (NIH), General Internal Medicine, Johns Hopkins School of Medicine, Biospective [Montréal], KG Jebsen Centre for Psychosis Research, University of Oslo (UiO)-Institute of Clinical Medicine-Oslo University Hospital [Oslo], Southwest Foundation for Biomedical Research, Department of Psychiatry and National Ageing Research Institute, University of Melbourne, Department of Clinical Genetics, Department of Medical Parasitology and Mycology, School of public health, The University of Hong Kong (HKU)-The University of Hong Kong (HKU)-Tehran University of Medical Siences, Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Departments of Psychiatry, Neurology, and Psychology, University of Pittsburgh (PITT), Pennsylvania Commonwealth System of Higher Education (PCSHE)-Pennsylvania Commonwealth System of Higher Education (PCSHE), The University of Texas Health Science Center at Houston (UTHealth), Texas Biomedical Research Institute [San Antonio, TX], 849 Department of Human Genetics, Dementia Collaborative Research Centre, Centre for Healthy Brain Ageing, Brain Center Rudolf Magnus, Department of Psychiatry, UMC Utrecht, Utrecht 3584 CX, The Netherlands, Université de Lausanne (UNIL), Department of Psychiatry [Boston], N.I. Vavilov Institute of General Genetics, Russian Academy of Sciences, Moscow 119333, Russia, Icahn School of Medicine at Mount Sinai [New York] (MSSM), The Mind Research Network, Department of Electrical and Computer Engineering [Albuquerque] (ECE Department), The University of New Mexico [Albuquerque], Human Genetics Branch, National Institutes of Health [Bethesda] (NIH)-National Institute of Mental Health (NIMH), Division of Molecular and Cellular Therapeutics, Metacohorts Consortium, Division of Medical Genetics, University of Basel (Unibas), Institute of Neuroscience and Medicine (INM-1), Research Center Juelich, Cell Biology and Gene Expression Section, National Institute of Health, Bethesda, Neuropsychiatric Genetics Research Group, Trinity College Dublin, Trinity College Dublin-St. James's Hospital, Department of Materials Science & Metallurgy, University of Cambridge [UK] (CAM), Bijvoet Center of Biomolecular Research [Utrecht], Utrecht University [Utrecht], VU University Amsterdam, Program in Translational NeuroPsychiatric Genomics, Brigham and Women's Hospital [Boston], Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, USA, Harvard Medical School [Boston] (HMS)-Massachusetts Institute of Technology (MIT)-Massachusetts General Hospital [Boston]-Harvard Medical School [Boston] (HMS)-Massachusetts Institute of Technology (MIT)-Massachusetts General Hospital [Boston], Harvard Medical School [Boston] (HMS), School of Psychology, University of Queensland, Neurology Division, Beaumont Hospital, Dublin 9, Ireland, Beaumont Hospital, Molecular and Cellular Therapeutics, Department of Neurology, Hôpital Erasme [Bruxelles] (ULB), Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB)-Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), Laboratory of Neurogenetics, Department of Genomics, Biological Psychology, Neuroscience Campus Amsterdam & EMGO Institute for Health and Care Research, VU University & VU Medical Center, Amsterdam 1081 BT, The Netherlands, Department of Radiology, Mayo Clinic, Department of Medical and Molecular Genetics, South Texas Veterans Health Care System, San Antonio, Texas 78229, USA, Department of Physics, Okayama University, Okayama University, National Institute of Aging, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital [Boston]-Harvard Medical School [Boston] (HMS), Public Health Genomics Unit, Department of Psychiatry and Psychotherapy, HELIOS Klinikum Stralsund Hanseatic-Greifswald University Hospital, Department of Mathematics, University of Colorado, University of Colorado [Boulder], Icelandic Heart Association, Kopavogur, Iceland., Faculty of Medicine, University of Iceland [Reykjavik], Department of Molecular Neurosciences, Institute of Neurology, UCL, Molecular Research Center for Children’s Mental Development, United Graduate School of Child Development, Osaka University [Osaka], Department of Psychiatry, University of Iowa, University of Iowa [Iowa City], University Medical Center Groningen [Groningen] (UMCG), Neuronal Plasticity / Mouse Behaviour, Interfaculty Institute for Genetics and Functional Genomics, Universität Greifswald - University of Greifswald, Tohoku University [Sendai], Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands, Stony Brook University [SUNY] (SBU), State University of New York (SUNY), Department of Medicine, Clinical Pharmacology Unit, Karolinska University Hospital [Stockholm], Centre for Allergy Research, Karolinska Institutet [Stockholm], Interuniversity Cardiology Institute Netherlands, Institute of Cognitive Neuroscience, School of Psychology, University of Sussex, Brighton BN1 9QH, UK, University of Sussex, Medical University of Łódź (MUL), Mayo Clinic [Rochester], University of Maryland School of Medicine, University of Maryland System-University of Maryland System-University of Maryland [Baltimore County] (UMBC), University of Maryland System, Department of Civil and Structural Engineering, The Hong Kong Polytechnic University [Hong Kong] (POLYU)-The Hong Kong Polytechnic University [Hong Kong] (POLYU), Université de Cergy Pontoise (UCP), Université Paris-Seine, Lymphocyte Cell Biology Unit, Laboratory of Genetics, Laboratoire de Statistique Théorique et Appliquée (LSTA), Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS), Psychiatry Institute, Department of Health and Human Services, Department of Life Sciences, Mathematical Sciences Institute (MSI), Australian National University (ANU), Centre for Advanced Imaging, Institute of Gerontology and Geriatrics, Università degli Studi di Perugia (UNIPG), Division of Mental Health and Addiction, Oslo University Hospital [Oslo], Institute of Clinical Medicine [Oslo], Faculty of Medicine [Oslo], Medical Faculty [Mannheim], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Genetic Epidemiology Unit, Université de Toulon - UFR Lettres et Sciences Humaines (UTLN UFR LSH), Université de Toulon (UTLN), Translational Centre for Regenerative Medicine (TRM), Department of Cell Therapy, Universität Leipzig [Leipzig]-Universität Leipzig [Leipzig], Institute of Clinical Chemistry and Laboratory Medicine, Warwick Manufacturing Group [Coventry] (WMG), University of Warwick [Coventry], Department of Statistics [Warwick], Delft University of Technology (TU Delft), Rheinische Friedrich-Wilhelms-Universität Bonn, Department of Health Science, Division of Health and Rehabilitation, Luleå University of Technology (LUT), University Medical Center [Utrecht]-Brain Center Rudolf Magnus, McConnell Brain Imaging Centre (MNI), Departments of Physiology and Nutritional Sciences, University of Toronto, Toronto, Canada, Psychiatry and Human Behavior, University of California, Irvine, California 92617, USA, Group Health Research Institute, Group Health Cooperative, Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health [Mannheim], Medical Faculty [Mannheim]-Medical Faculty [Mannheim], Cedars-Sinai Medical Center, Centre for Healthy Brain Ageing [Sydney], The University of Sydney, Genetics of Mental Illness and Brain Function, Neuroscience Research Australia, Broad Institute [Cambridge], Harvard University [Cambridge]-Massachusetts Institute of Technology (MIT), Department of Medical Biochemistry and Microbiology, Department of Clinical and Experimental Epilepsy, Department of neurology, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland, Department of neurology, University of Eastern Finland-University Hospital of Kuopio-University of Eastern Finland-University Hospital of Kuopio, Stroke and Ageing Research Centre, Southern Clinical School, Department of Medicine, Monash University, Monash University [Melbourne], Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, University of Tasmania [Hobart, Australia] (UTAS), Institute of Cardiovascular and Medical Sciences [Glasgow], University of Glasgow, Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney 2052, Australia, Department of Epidemiology, Laboratory of Neuro Imaging [Los Angeles] (LONI), University of York [York, UK], Epidémiologie et Biostatistique [Bordeaux], Université Bordeaux Segalen - Bordeaux 2-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Genentech, Inc. [San Francisco], Departments of Radiology and of Epidemiology [Rotterdam], Psychiatry and Leiden Institute for Brain and Cognition, Department of Neurology [Rotterdam], Institute for Community Medicine, Berlin School of Mind and Brain [Berlin], Humboldt-Universität zu Berlin, Carver College of Medicine [Iowa City], University of Iowa [Iowa City]-University of Iowa [Iowa City], Centre for Population Health Sciences, Department of Physics [Hong Kong University of Science and Technology], Hong Kong University of Science and Technology (HKUST), Department of Neurobiology, Care Sciences and Society, Research Laboratory for Archaeology & the History of Art, Singapore Eye Research Institute, Singapore National Eye Centre, School of Life Sciences, Arizona State University [Tempe] (ASU), Department of Neurology and Center for Neuroscience, University of California at Davis, Sacramento, University of California [Davis] (UC Davis), Dpt of Pharmacology and Personalised Medicine [Maastricht], Maastricht University [Maastricht], University of Missouri [Columbia] (Mizzou), University of Missouri System, Göttingen Zentrum Geowissenschaften, Georg-August-University [Göttingen], Human Genetics Center, Psychiatry, EMGO - Mental health, Amsterdam Neuroscience - Complex Trait Genetics, Anatomy and neurosciences, Klinische Genetica, MUMC+: DA Klinische Genetica (5), RS: FHML non-thematic output, RS: GROW - School for Oncology and Reproduction, RS: GROW - R4 - Reproductive and Perinatal Medicine, Genetica & Celbiologie, Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Chimie du CNRS (INC)-Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Institut de Chimie du CNRS (INC)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Vrije universiteit = Free university of Amsterdam [Amsterdam] (VU), University of Maryland [Baltimore County] (UMBC), University of Maryland System-University of Maryland System-University of Maryland School of Medicine, Centre National de la Recherche Scientifique (CNRS)-Université Pierre et Marie Curie - Paris 6 (UPMC), Universidad de Cantabria, Universiteit Leiden, Radboud University [Nijmegen], University of California (UC), Universität Heidelberg [Heidelberg] = Heidelberg University, Universität Bonn = University of Bonn, [GIN] Grenoble Institut des Neurosciences (GIN), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Yale School of Medicine [New Haven, Connecticut] (YSM), Department of Cognitive Sciences [Univ California San Diego] (CogSci - UC San Diego), University of California (UC)-University of California (UC), Department of Neurosciences [Univ California San Diego] (Neuro - UC San Diego), School of Medicine [Univ California San Diego] (UC San Diego), University of California (UC)-University of California (UC)-University of California [San Diego] (UC San Diego), Institut Pasteur [Paris] (IP)-Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), King Faisal Specialist Hospital and Research Centre (KFSH & RC), Universiteit Leiden-Universiteit Leiden, University of Twente, University of California [Irvine] (UC Irvine), Radboud University [Nijmegen]-Radboud University [Nijmegen], Centre épigénétique et destin cellulaire (EDC), Université Paris Diderot - Paris 7 (UPD7)-Centre National de la Recherche Scientifique (CNRS), Université de Lausanne = University of Lausanne (UNIL), Harvard Medical School [Boston] (HMS)-Massachusetts General Hospital [Boston], Università degli Studi di Perugia = University of Perugia (UNIPG), University Hospital Mannheim | Universitätsmedizin Mannheim, Universität Leipzig-Universität Leipzig, University Hospital Mannheim | Universitätsmedizin Mannheim-University Hospital Mannheim | Universitätsmedizin Mannheim, Harvard University-Massachusetts Institute of Technology (MIT), University of Eastern Finland, Humboldt University Of Berlin, Georg-August-University = Georg-August-Universität Göttingen, Interdisciplinary Centre Psychopathology and Emotion regulation (ICPE), Clinical Cognitive Neuropsychiatry Research Program (CCNP), Epidemiology, Child and Adolescent Psychiatry / Psychology, Ophthalmology, Radiology & Nuclear Medicine, Internal Medicine, Neurosciences, Obstetrics & Gynecology, Neurology, EMGO+ - Mental Health, Biological Psychology, Facteurs de Risque et Déterminants Moléculaires des Maladies liées au Vieillissement (Inserm U1167 - RID-AGE - Institut Pasteur), McGill University-McGill University, National Heart, Lung, and Blood Institute [Bethesda] (NHLBI)-Boston University [Boston] (BU), McGill University, Technische Universität Dresden (TUD), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Descartes - Paris 5 (UPD5), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Cochin [AP-HP], University of Bergen (UIB), Université de Lorraine (UL)-Centre National de la Recherche Scientifique (CNRS), Institut des Maladies Neurodégénératives [Bordeaux] (IMN), Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS)-Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), University of Minnesota [Twin Cities], Karakter Child and Adolescent Psychiatry University Center Nijmegen, Centre National de la Recherche Scientifique (CNRS)-Université Paris Diderot - Paris 7 (UPD7)-Institut Pasteur [Paris], Centre Hospitalier Universitaire [Grenoble] (CHU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes (UGA), Texas Biomedical Research Institute [San Antonio, Texas], Bijvoet Center of Biomolecular Research, Université Libre de Bruxelles [Bruxelles] (ULB)-Hôpital Erasme (Bruxelles), Okayama University [Okayama], Charité - Universitätsmedizin Berlin / Charite - University Medicine Berlin, Massachusetts Institute of Technology (MIT)-Harvard University [Cambridge], University of Tasmania (UTAS), Humboldt Universität zu Berlin, Department of Physics [Kowloon], University of Missouri [Columbia], Georg-August-Universität Göttingen, and the Alzheimer's Disease Neuroimaging Initiative, EPIGEN, IMAGEN, SYS
- Subjects
0301 basic medicine ,Netherlands Twin Register (NTR) ,Genome-wide association study ,Disease ,methods [Genome-Wide Association Study] ,Genome-wide association studies ,Phosphatidylinositol 3-Kinases ,0302 clinical medicine ,Cognition ,PARKINSONS-DISEASE ,pathology [Brain] ,genetics [Parkinson Disease] ,610 Medicine & health ,General Neuroscience ,growth & development [Brain] ,physiology [Cognition] ,220 Statistical Imaging Neuroscience ,COMMON VARIANTS ,Brain ,Parkinson Disease ,Phenotype ,17Q21.31 MICRODELETION ,IGF-I ,genetics [Oncogene Protein v-akt] ,Oncogene Protein v-akt ,ALZHEIMERS-DISEASE ,HEAD CIRCUMFERENCE ,Brain size ,genetics [Polymorphism, Single Nucleotide] ,Medical genetics ,GROWTH ,Neuroinformatics ,medicine.medical_specialty ,Neuroscience(all) ,European Continental Ancestry Group ,genetics [Genetic Loci] ,Biology ,Genetic correlation ,Polymorphism, Single Nucleotide ,150 000 MR Techniques in Brain Function ,Article ,White People ,03 medical and health sciences ,Image processing ,SDG 3 - Good Health and Well-being ,ddc:570 ,medicine ,Journal Article ,Humans ,Genetic Predisposition to Disease ,Gene ,METAANALYSIS ,Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7] ,Neurology & Neurosurgery ,Neuroscience (all) ,Height ,[SCCO.NEUR]Cognitive science/Neuroscience ,CONSORTIUM ,Development of the nervous system ,1702 Cognitive Science ,030104 developmental biology ,Genetic Loci ,Human genome ,BRAIN SIZE ,1109 Neurosciences ,genetics [Phosphatidylinositol 3-Kinases] ,Neuroscience ,030217 neurology & neurosurgery ,Genome-Wide Association Study - Abstract
Contains fulltext : 165723pub.pdf (Publisher’s version ) (Closed access) Intracranial volume reflects the maximally attained brain size during development, and remains stable with loss of tissue in late life. It is highly heritable, but the underlying genes remain largely undetermined. In a genome-wide association study of 32,438 adults, we discovered five previously unknown loci for intracranial volume and confirmed two known signals. Four of the loci were also associated with adult human stature, but these remained associated with intracranial volume after adjusting for height. We found a high genetic correlation with child head circumference (rhogenetic = 0.748), which indicates a similar genetic background and allowed us to identify four additional loci through meta-analysis (Ncombined = 37,345). Variants for intracranial volume were also related to childhood and adult cognitive function, and Parkinson's disease, and were enriched near genes involved in growth pathways, including PI3K-AKT signaling. These findings identify the biological underpinnings of intracranial volume and their link to physiological and pathological traits.
- Published
- 2016
48. Higher Frequency of Atrial Fibrillation Linked to Colder Seasons and Air Temperature on the Day of Ischemic Stroke Onset
- Author
-
Susan Gabriela Lakkis, María Martha Esnaola y Rojas, Osvaldo Fustinoni, Gustavo Saposnik, Luciano A. Sposato, Instituto de Neurociencias (Argentina), St Michael’s Hospital (Canada). Stroke Outcomes Research Center, University of Toronto (Canada). Department of Medicine, University of Toronto (Canada). Department of Health Policy Management and Evaluation, Institute for Clinical Evaluative Sciences (Canada), Hospital Dr. Cesar Milstein (Argentina). Departamento de Neurología, Universidad Católica Argentina (Buenos Aires). Equipo Interdisciplinario para el Estudio del Cambio Global, Fundación Favaloro (Argentina), and Fundación INECO (Argentina)
- Subjects
medicine.medical_specialty ,business.industry ,ESTACIONES METEOROLOGICAS ,Rehabilitation ,Atrial fibrillation ,Odds ratio ,Seasonality ,medicine.disease ,ACCIDENTE CEREBROVASCULAR ,TEMPERATURA ,Internal medicine ,Air temperature ,TIEMPO ,Cohort ,Ischemic stroke ,medicine ,Cardiology ,FIBRILACION AURICULAR ,Surgery ,cardiovascular diseases ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,business ,Stroke ,Chi-squared distribution - Abstract
Fil: Osvaldo Fustinoni. Instituto de Neurociencias Buenos Aires; Argentina Fil: Gustavo Saposnik. Universidad de Toronto. Departamento de Medicina; Argentina Fil: Gustavo Saposnik. Instituto de Ciencias de la Evaluación Clínica; Canadá Fil: Esnaola y Rojas, María Martha. Hospital Dr. Cesar Milstein. Departamento de Neurología; Argentina Fil: Lakkis, Susan Gabriela. Pontificia Universidad Católica Argentina. Facultad de Ciencias Agrarias. Equipo Interdisciplinario para el Estudio de Procesos Atmosféricos en el Cambio Global; Argentina Fil: Sposato, Luciano A. Fundación Favaloro; Argentina Background: Whether a seasonal variation of atrial fibrillation among acute ischemic stroke (AIS) patients occurs is unknown. We studied the distribution of atrial fibrillation across seasons and air temperatures in a cohort of AIS patients. Methods: We selected 899 AIS patients from the Argentinean Stroke Registry (ReNACer), who were admitted to 43 centers in the Province of Buenos Aires. We recorded the minimum and maximum temperatures at local weather centers on the day and the city where each stroke occurred. We used the goodness-of-fit c2 test to assess the distribution of atrial fibrillation across seasons and air temperatures and the Pearson correlation coefficient to assess the relationship between these variables.We developed a regression model for testing the association between seasons and atrial fibrillation. Results: We found a seasonal variation in the occurrence of atrial fibrillation, with a peak in winter and a valley in summer (23.1% versus 14.0%, P,.001). The semester comprised by autumn and winter was associated with atrial fibrillation (Pearson P ,.001). Atrial fibrillation showed a nonhomogeneous distribution across ranges of temperature (P , .001, goodness-of-fit test), with a peak between 5C and 9C, and was associated with minimum (Pearson P 5 .042) and maximum (Pearson P 5.002) air temperature. After adjusting for significant covariates, there was a 2- fold risk of atrial fibrillation during autumn and winter. Conclusions: In this cohort of AIS patients, atrial fibrillation showed a seasonal variation and a nonhomogeneous distribution across air temperatures, with peaks in cold seasons and low temperatures on the day of stroke onset. Key Words: Ischemic stroke—atrial fibrillation—risk—season—temperature—weather
- Published
- 2013
49. White Matter Lesion Progression
- Author
-
Hofer, Edith, Cavalieri, Margherita, Bis, Joshua C., DeCarli, Charles, Fornage, Myriam, Sigurdsson, Sigurdur, Srikanth, Velandai, Trompet, Stella, Verhaaren, Benjamin F.J., Wolf, Chris, Yang, Qiong, Adams, Hieab H.H., Amouyel, Philippe, Beiser, Alex, Buckley, Brendan M., Callisaya, Michele, Chauhan, Ganesh, De Craen, Anton J.M., Dufouil, Carole, Van Duijn, Cornelia M., Ford, Ian, Freudenberger, Paul, Gottesman, Rebecca F., Gudnason, Vilmundur, Heiss, Gerardo, Hofman, Albert, Lumley, Thomas, Martinez, Oliver, Mazoyer, Bernard, Moran, Chris, Niessen, Wiro J., Phan, Thanh, Psaty, Bruce M., Satizabal, Claudia L., Sattar, Naveed, Schilling, Sabrina, Shibata, Dean K., Slagboom, P. Eline, Smith, Albert, Stott, David J., Taylor, Kent D., Thomson, Russell, Töglhofer, Anna M., Tzourio, Christophe, van Buchem, Mark, Wang, Jing, Westendorp, Rudi G.J., Gwen Windham, B., Vernooij, Meike W., Zijdenbos, Alex, Beare, Richard, Debette, Stéphanie, Ikram, M. Arfan, Jukema, J. Wouter, Launer, Lenore J., Longstreth, W. T., Mosley, Thomas H., Seshadri, Sudha, Schmidt, Helena, Schmidt, Reinhold, Department of Neurology, Medical University Graz, Graz, Austri, University of Washington [Seattle], Department of Neurology and Center for Neuroscience, University of California at Davis, Sacramento, University of California [Davis] (UC Davis), University of California (UC)-University of California (UC), Human Genetics Center, The University of Texas Health Science Center at Houston (UTHealth), Department of Medical Biochemistry and Microbiology, Uppsala University, Broad Institute [Cambridge], Harvard University-Massachusetts Institute of Technology (MIT), Stroke and Ageing Research Centre, Southern Clinical School, Department of Medicine, Monash University, Monash University [Melbourne], Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia, University of Tasmania [Hobart, Australia] (UTAS), Interuniversity Cardiology Institute Netherlands, Erasmus University Medical Center [Rotterdam] (Erasmus MC), Anhui University [Hefei], Institut Gilbert-Laustriat : Biomolécules, Biotechnologie, Innovation Thérapeutique, Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Université de Lille, Boston University [Boston] (BU), Boston University School of Medicine (BUSM), INSERM Research Center for Epidemiology and Biostatistics (U897) Team Neuroepidemiology, Bordeaux, France College of Health Sciences, University of Bordeaux, Bordeaux, France, Department of neurology, Leiden University Medical Center (LUMC), Universiteit Leiden-Universiteit Leiden, Epidémiologie et Biostatistique [Bordeaux], Université Bordeaux Segalen - Bordeaux 2-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institute of Molecular Biology & Biochemistry, Johns Hopkins University School of Medicine [Baltimore], Icelandic Heart Association, Kopavogur, Iceland., Faculty of Medicine, University of Iceland [Reykjavik], University of North Carolina [Chapel Hill] (UNC), University of North Carolina System (UNC), Department of Biostatistics, University of Washington, Institut de pharmacologie et de biologie structurale (IPBS), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS), Groupe d'Imagerie Neurofonctionnelle (GIN - UMR 5296), Service NEUROSPIN (NEUROSPIN), Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS), Wellcome Trust - MRC Cambridge, Delft University of Technology (TU Delft), Group Health Research Institute, Group Health Cooperative, INSERM, Neuroepidemiology U708, Bordeaux, France, Department of Pathological Biochemistry, Royal Infirmary, Department for Internal Medicine, Staedtische Kliniken Moenchengladbach, Department of Radiology, University of Washington, Section of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands Consortium for Healthy Aging, Leiden University Medical Center, Leiden, the Netherlands, Institute of Cardiovascular and Medical Sciences [Glasgow], University of Glasgow, Institute of Molecular Biology and Biochemistry, Centre for Molecular Medicine, Medical University of Graz, Graz, Austria, Department of Radiology [Leiden, The Netherlands], Leids Universitair Medisch Centrum [Leiden, The Netherlands], Laboratoire d'Etude des NanoStructures et Imagerie de Surface (LENSIS), Service de physique de l'état condensé (SPEC - UMR3680), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)-Institut Rayonnement Matière de Saclay (IRAMIS), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay, Department of Gerontology and Geriatrics, Netherlands Consortium for Healthy Ageing, Department of Neurology [Rotterdam], Departments of Radiology and of Epidemiology [Rotterdam], Biospective [Montréal], Murdoch Children's Research Institute (MCRI), Netherlands Consortium for Healthy Ageing, Leiden, The Netherlands, University of Mississippi Medical Center (UMMC), Department of Neurology [Boston, USA], Boston University [Boston] (BU)-Boston University [Boston] (BU), Dpt of Pharmacology and Personalised Medicine [Maastricht], Maastricht University [Maastricht], University of California-University of California, Harvard University [Cambridge]-Massachusetts Institute of Technology (MIT), Centre National de la Recherche Scientifique (CNRS)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées, Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS)-Service NEUROSPIN (NEUROSPIN), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), and Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay
- Subjects
white matter lesions ,[SCCO.NEUR]Cognitive science/Neuroscience ,aging ,magnetic resonance imaging ,cerebral small vessel diseases ,biological factors - Abstract
International audience; Background and Purpose—White matter lesion (WML) progression on magnetic resonance imaging is related to cognitive decline and stroke, but its determinants besides baseline WML burden are largely unknown. Here, we estimated heritability of WML progression, and sought common genetic variants associated with WML progression in elderly participants from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.Methods—Heritability of WML progression was calculated in the Framingham Heart Study. The genome-wide association study included 7773 elderly participants from 10 cohorts. To assess the relative contribution of genetic factors to progression of WML, we compared in 7 cohorts risk models including demographics, vascular risk factors plus single-nucleotide polymorphisms that have been shown to be associated cross-sectionally with WML in the current and previous association studies.Results—A total of 1085 subjects showed WML progression. The heritability estimate for WML progression was low at 6.5%, and no single-nucleotide polymorphisms achieved genome-wide significance (P
- Published
- 2015
50. Arterial stiffness, physical function, and functional limitation: the Whitehall II Study.: Arterial Stiffness and Functioning
- Author
-
C. M. McEniery, Annie Britton, Ian B. Wilkinson, Daniel R. Witte, Archana Singh-Manoux, Adam G. Tabak, Martin J. Shipley, Eric J. Brunner, Mika Kivimäki, Department of Epidemiology and Public Health, University College of London [London] (UCL), Steno Diabetes Center, University of Copenhagen = Københavns Universitet (KU), Centre de Gérontologie, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Sainte Perine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Santé publique et épidémiologie des déterminants professionnels et sociaux de la santé, Epidémiologie, sciences sociales, santé publique (IFR 69), Université Paris 1 Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris 1 Panthéon-Sorbonne (UP1)-Université Paris-Sud - Paris 11 (UP11)-École des hautes études en sciences sociales (EHESS)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), 1st Department of Medicine, Semmelweis University of Medicine [Budapest], Clinical Pharmacology Unit, University of Cambridge [UK] (CAM)-Addenbrooke's Hospital, The Whitehall II study has been supported by grants from the British Medical Research Council, British Economic and Social Research Council, British Heart Foundation, Stroke Association, UK Health and Safety Executive, UK Department of Health, National Heart Lung and Blood Institute (HL36310), US, National Institutes of Health: National Institute on Aging (R01AG013196, R01AG034454, US, National Institutes of Health, Agency for Health Care Policy Research (HS06516), and and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. ARB, EJB, MK, CMM (Intermediate Research Fellowship), MJS and IBW (Senior Clinical Fellowship) are supported by the British Heart Foundation. MK is supported by BUPA and the Academy of Finland. EJB and ARB are supported by the Stroke Association. IBW and CMM are supported by the Cambridge Biomedical Research Centre (NIHR).
- Subjects
Male ,Epidemiology ,MESH: Vascular Resistance ,Blood Pressure ,030204 cardiovascular system & hematology ,Pulmonary function testing ,0302 clinical medicine ,Surveys and Questionnaires ,Activities of Daily Living ,Medicine ,MESH: Aging ,Longitudinal Studies ,030212 general & internal medicine ,MESH: Longitudinal Studies ,Pulse wave velocity ,Aorta ,MESH: Aged ,MESH: Middle Aged ,medicine.diagnostic_test ,Age Factors ,MESH: Aorta ,MESH: Blood Flow Velocity ,MESH: Blood Pressure ,Middle Aged ,MESH: Motor Activity ,Pulse pressure ,arterial stiffness ,Pulsatile Flow ,MESH: Pulsatile Flow ,Female ,Aortic stiffness ,Blood Flow Velocity ,Spirometry ,Mean arterial pressure ,medicine.medical_specialty ,Motor Activity ,Article ,03 medical and health sciences ,physical function ,Internal Medicine ,Humans ,functional limitation ,Aged ,MESH: Age Factors ,MESH: Humans ,business.industry ,MESH: Questionnaires ,aging ,MESH: Activities of Daily Living ,pulse pressure ,medicine.disease ,MESH: Male ,Blood pressure ,Arterial stiffness ,Physical therapy ,Vascular Resistance ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,business ,MESH: Female - Abstract
International audience; Arterial stiffness has been proposed as an indicator of vascular aging. We aimed to examine this concept by analyzing associations of arterial stiffness with age, subjective and objective measures of physical functioning, and self-reported functional limitation. We measured aortic pulse wave velocity by applanation tonometry among 5392 men and women aged 55 to 78 years. Arterial stiffness was strongly associated with age (mean difference [SE] per decade: men, 1.37 m/s [0.06 m/s]; women: 1.39 m/s [0.10 m/s]). This association was robust to individual and combined adjustment for pulse pressure, mean arterial pressure, antihypertensive treatment, and chronic disease. Participants took an 8.00-ft (2.44-m) walking speed test, a spirometry lung function test, and completed health functioning and (instrumental) activities of daily living questionnaires. Associations of stiffness and blood pressure with physical function scores scaled to SD of 10 were compared. One-SD higher stiffness was associated with lower walking speed (coefficient [95% CI]: -0.96 [-1.29 to -0.64] m/s) and physical component summary score (-0.91 [-1.21 to -0.60]) and poorer lung function (-1.23 [-1.53 to -0.92] L) adjusted for age, sex, and ethnic group. Pulse pressure and mean arterial pressure were linked inversely only with lung function. Associations of stiffness with functional limitation were robust to multiple adjustment, including pulse pressure and chronic disease. In conclusion, the concept of vascular aging is reinforced by the observation that arterial stiffness is a robust correlate of physical functioning and functional limitation in early old age. The nature of the link between arterial stiffness and quality of life in older people merits attention.
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.